Showing results (491-500 of 505) with videos related to

Sort By:
Pageof 51
Journal of Hypertension|December 5, 2006
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicityPatrice M Ambühl, Alain C Tissot, Alma Fulurija, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2019
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergensFederico Storni, Andris Zeltins, Ina Balke, et al.
Allergy|March 8, 2023
The next generation virus-like particle platform for the treatment of peanut allergyJan M Sobczak, Pascal S Krenger, Federico Storni, et al.
Annals of Medicine|February 8, 2022
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccinesQueenie Fernandes, Varghese Philipose Inchakalody, Maysaloun Merhi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patientsDaniel E Speiser, Katrin Schwarz, Petra Baumgaertner, et al.
Journal for Immunotherapy of Cancer|May 25, 2019
Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Journal for Immunotherapy of Cancer|April 28, 2019
Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Pageof 51